Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients

Cellular Immunology

Volumn 266, Issue 1, 2010, Pages 52-60

  Yassin, Lina M ^a   Rojas, Mauricio ^a   Ramírez, Luis A ^a   García, Luis F ^a   Vásquez, Gloria ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Apoptosis; Clearance; Monocytes; Scavenger receptors; SLE

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; B7 ANTIGEN; CAPTOPRIL; CD163 ANTIGEN; CD36 ANTIGEN; CHLOROQUINE; CYCLOPHOSPHAMIDE; HLA DR ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; WARFARIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD36; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; ATHEROSCLEROSIS; CHEMOKINE CCL2; CHEMOKINE CCL22; CHEMOKINE CCL3; CULTURE MEDIA, CONDITIONED; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77958489320     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.08.012     Document Type: Article

References (53)

1. Emlen W., Niebur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 1994, 152:3685-3692.
2. Gaipl U.S., Munoz L.E., Grossmayer G., Lauber K., Franz S., Sarter K., Voll R.E., Winkler T., Kuhn A., Kalden J., Kern P., Herrmann M. Clearance deficiency and systemic lupus erythematosus (SLE). J. Autoimmun. 2007, 28:114-121.
3. Savill J., Hogg N., Ren Y., Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 1992, 90:1513-1522.
4. Ren Y., Silverstein R.L., Allen J., Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 1995, 181:1857-1862.
5. Platt N., da Silva R.P., Gordon S. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol. 1998, 8:365-372.
6. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
7. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392:86-89.
8. Uchimura E., Kodaira T., Kurosaka K., Yang D., Watanabe N., Kobayashi Y. Interaction of phagocytes with apoptotic cells leads to production of pro-inflammatory cytokines. Biochem. Biophys. Res. Commun. 1997, 239:799-803.
9. Kurosaka K., Watanabe N., Kobayashi Y. Production of proinflammatory cytokines by phorbol myristate acetate-treated THP-1 cells and monocyte-derived macrophages after phagocytosis of apoptotic CTLL-2 cells. J. Immunol. 1998, 161:6245-6249.
10. Lorimore S.A., Coates P.J., Scobie G.E., Milne G., Wright E.G. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects?. Oncogene 2001, 20:7085-7095.
11. Ren Y., Xie Y., Jiang G., Fan J., Yeung J., Li W., Tam P.K., Savill J. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J. Immunol. 2008, 180:4978-4985.
12. Andrade F., Casciola-Rosen L.A., Rosen A. Generation of novel covalent RNA-protein complexes in cells by ultraviolet B irradiation: implications for autoimmunity. Arthritis Rheum. 2005, 52:1160-1170.
13. Reefman E., de Jong M.C., Kuiper H., Jonkman M.F., Limburg P.C., Kallenberg C.G., Bijl M. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?. Arthritis Res. Ther. 2006, 8:R156.
14. Caricchio R., McPhie L., Cohen P.L. Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J. Immunol. 2003, 171:5778-5786.
15. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben-Tal O., Kutikov I., Gill O., Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 2002, 196:1553-1561.
16. Peiser L., Gordon S. The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes. Infect. 2001, 3:149-159.
17. Freire-de-Lima C.G., Nascimento D.O., Soares M.B., Bozza P.T., Castro-Faria-Neto H.C., de Mello F.G., DosReis G.A., Lopes M.F. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 2000, 403:199-203.
18. Moestrup S.K., Moller H.J. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann. Med. 2004, 36:347-354.
19. Murphy J.E., Tedbury P.R., Homer-Vanniasinkam S., Walker J.H., Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 2005, 182:1-15.
20. Platt N., Suzuki H., Kurihara Y., Kodama T., Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. USA 1996, 93:12456-12460.
21. Podrez E.A., Febbraio M., Sheibani N., Schmitt D., Silverstein R.L., Hajjar D.P., Cohen P.A., Frazier W.A., Hoff H.F., Hazen S.L. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 2000, 105:1095-1108.
22. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Kodama T., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386:292-296.
23. Hahn B.H., Grossman J., Chen W., McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J. Autoimmun. 2007, 28:69-75.
24. Aprahamian T., Rifkin I., Bonegio R., Hugel B., Freyssinet J.M., Sato K., Castellot J.J., Walsh K. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 2004, 199:1121-1131.
25. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
26. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on prognosis studies in SLE. Arthritis Rheum. 1992, 35:630-640.
27. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2:965-975.
28. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2001, 2:123-128.
29. Rovin B.H., Phan L.T. Chemotactic factors and renal inflammation. Am. J. Kidney Dis. 1998, 31:1065-1084.
30. Garcia G.E., Truong L.D., Li P., Zhang P., Du J., Chen J.F., Feng L. Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis. Faseb. J. 2008, 22:445-454.
31. Li Y., Tucci M., Narain S., Barnes E.V., Sobel E.S., Segal M.S., Richards H.B. Urinary biomarkers in lupus nephritis. Autoimmun. Rev. 2006, 5:383-388.
32. Stuart L.M., Lucas M., Simpson C., Lamb J., Savill J., Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 2002, 168:1627-1635.
33. Rumore P.M., Steinman C.R. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 1990, 86:69-74.
34. Zorro S., Arias M., Riano F., Paris S., Ramirez L., Uribe O., Garcia L., Vasquez G. Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity. Lupus 2009, 18:718-726.
35. Mueller D.L., Jenkins M.K., Schwartz R.H. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 1989, 7:445-480.
36. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991, 174:561-569.
37. Linsley P.S., Greene J.L., Brady W., Bajorath J., Ledbetter J.A., Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994, 1:793-801.
38. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. The B7 and CD28 receptor families. Immunol. Today 1994, 15:321-331.
39. Mok C.C., Lau C.S. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 2003, 56:481-490.
40. Clayton A.R., Prue R.L., Harper L., Drayson M.T., Savage C.O. Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum. 2003, 48:2362-2374.
41. Kurosaka K., Takahashi M., Watanabe N., Kobayashi Y. Silent cleanup of very early apoptotic cells by macrophages. J. Immunol. 2003, 171:4672-4679.
42. Bijl M., Reefman E., Limburg P.C., Kallenberg C.G. Inflammatory clearance of apoptotic cells after UVB challenge. Autoimmunity 2007, 40:244-248.
43. Iida N., Nakamoto Y., Baba T., Kakinoki K., Li Y.Y., Wu Y., Matsushima K., Kaneko S., Mukaida N. Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice. J. Leukoc. Biol. 2008, 84:1001-1010.
44. Ren Y., Tang J., Mok M.Y., Chan A.W., Wu A., Lau C.S. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 2003, 48:2888-2897.
45. Hermann J.A., Hall M.A., Maini R.N., Feldmann M., Brennan F.M. Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum. 1998, 41:1388-1397.
46. Peiser L., Gough P.J., Kodama T., Gordon S. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun. 2000, 68:1953-1963.
47. Cairns A.P., Crockard A.D., Bell A.L. CD36-mediated apoptotic cell clearance in SLE. Lupus 2001, 10:656-657.
48. Baeten D., Demetter P., Cuvelier C.A., Kruithof E., Van Damme N., De Vos M., Veys E.M., De Keyser F. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J. Pathol. 2002, 196:343-350.
49. + T lymphocyte-rich microenvironments. Arthritis Rheum. 2002, 46:1210-1216.
50. + monocytes of patients with coronary heart disease. Clin. Exp. Pharmacol. Physiol. 2008, 35:552-556.
51. Yamashita S., Hirano K., Kuwasako T., Janabi M., Toyama Y., Ishigami M., Sakai N. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol. Cell. Biochem. 2007, 299:19-22.
52. Baba M.I., Kaul D., Grover A. Pathognomonic genetic expression profile within peripheral blood mononuclear cells of rheumatic heart disease patients. Mol. Cell. Biochem. 2006, 291:213-217.
53. Greenwalt D.E., Scheck S.H., Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest. 1995, 96:1382-1388.